• Advertise
  • Contact Us
  • Subscribe
  • Follow
  • Follow
Pharmafile Logo
  • Home
  • Publications
    • European Biopharmaceutical Review
    • European Pharmaceutical Contractor (EPC)
    • Innovations in Pharmaceutical Technology (IPT)
    • International Clinical Trials (ICT)
    • Pharmaceutical Manufacturing and Packing Sourcer (PMPS)
    • Pharmafocus
    • Pharmafile
  • Conferences
  • News & Press Releases
  • Directory
  • Subscribe

PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego

Samedan Ltd|Apr 18, 2023| Uncategorized

PHILADELPHIA - April 18, 2023 -PCI Pharma Services (PCI), a leading global contract development and manufacturing...

Headlands Research Acquires Established Eastern Massachusetts‚Ä’Based Research Site Specializing in Neurodegenerative Diseases

Samedan Ltd|Apr 18, 2023| Uncategorized

San Francisco, CA, April 18, 2023 ó Headlands Research, a leading multinational network of clinical trial sites, today...

NeoPhore signs research collaboration with The Institute of Cancer Research, London

Samedan Ltd|Apr 18, 2023| Uncategorized

London, UK, 18 April 2023, - NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces...

Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favourable Tolerability and Immunogenicity Profile

Samedan Ltd|Apr 17, 2023| Uncategorized

OXFORD, United Kingdom, 17 April, 2023 (GLOBE NEWSWIRE) - Vaccitech plc (NASDAQ: VACC), a clinical-stage...

Transgene – Preclinical Results Showing TG6050, a Novel Oncolytic Virus, induces Tumor Regression by Activating Innate and Adaptive immune responses presented at AACR

Samedan Ltd|Apr 17, 2023| Uncategorized

Strasbourg, France, April 17, 2023, 7:30 a.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs...

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme

Samedan Ltd|Apr 11, 2023| Uncategorized

London, UK and Durham, NC - April 11, 2023: Specialist biometrics CRO Phastar has supported a Great Ormond Street...

Innovative Trials Appoints First Commercial Vice President to Drive Business Growth Worldwide

Innovative Trials Appoints First Commercial Vice President to Drive Business Growth Worldwide

Samedan Ltd|Apr 5, 2023| Uncategorized

Innovative Trials, a globally-focused company specializing in clinical trial patient recruitment, retention and...

WuXi STA Adds New Peptide Manufacturing Capacity and Large-Scale Continuous Purification System

Samedan Ltd|Apr 5, 2023| Uncategorized

Shanghai, China, 5 April 2023: WuXi STA, a global Contract Research, Development, and Manufacturing Organization...

CluePoints Announces Amit Patel as New CFO

Samedan Ltd|Apr 5, 2023| Uncategorized

King of Prussia, PA - April 5th, 2023: RBQM leader, CluePoints, has today announced that Amit Patel will join as the...

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Samedan Ltd|Apr 4, 2023| Uncategorized

Cambridge, UK, 04 April 2023 - Mosaic Therapeutics, Ltd, (ëMosaicí, or ëthe Companyí) an oncology therapeutics company...

TransCure bioServices expands their team to lead the way in animal welfare

Samedan Ltd|Apr 3, 2023| Uncategorized

Archamps, (3 April 2023) - TransCure bioServices, a unique fee-for-service Humanized Mouse Preclinical CRO, has...

TOWER COLD CHAIN SECURES SPOT IN FINANCIAL TIMES TOP 1000 FASTEST-GROWING COMPANIES

Samedan Ltd|Mar 23, 2023| Uncategorized

 Temperature-controlled container specialist, Tower Cold Chain, has secured a position in the Financial Times annual...

Older Entries
Next Entries
European Biopharmaceutical Review
European Pharmaceutical Contractor
Innovations in Pharmaceutical Technology
International Clinical Trials
Pharmaceutical Manufacturing and Packing Sourcer
Pharmafile
Pharmafile.com
Pharmafocus
  • About Samedan
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (UK)
All content copyright © Samedan Ltd 2026
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}